Light-based immune boost to help prevent viral upper respiratory infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares an active photobiomodulation device (RD-X19) with a sham device in adults 18+ working at a DoD and VA medical facility. Participants use the device at home every other day for five minutes, starting from enrollment, with baseline and symptom-driven viral PCR testing to identify infections. Research staff monitor symptoms biweekly and perform daily check-ins during active illness to track outcomes such as symptom duration, work days missed, healthcare visits, and medication use. Eligibility focuses on active duty or DoD beneficiaries at the Mike O’Callaghan Military Medical Center, with exclusions for procedures that would interfere with device use. The study aims to determine whether this home-use device can reduce incidence and impact of respiratory viral infections.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Active Duty and DoD Beneficiaries (i.e. former military, spouse, dependent child) aged 18 years and older who work in the Mike O'Callaghan Military Medical Center at Nellis Air Force Base.

Exclusion Criteria:

* Unable to comfortably insert RD-X19 into the mouth and keep in place for 5 minutes
* Plans for head, neck or mouth surgery during the study period
* Plans for major dental procedures (ie implants, wisdom teeth extraction etc) during the study

Where it's running

• Mike O'Callaghan Military Medical Center
  Nellis Air Force Base, Nevada, United States Recruiting

Study contacts

• Study coordinator: Sandra Huffman
• Email: Sandra.g.huffman.ctr@health.mil
• Phone: 7026533583

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy

  This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.

  Recruiting Phase 2 Asan Medical Center · Seoul · NCT07926217

• Abbott ID NOW at the point of care for flu-like illness in long-term care facilities

  This trial tests whether the Abbott ID NOW rapid test at the point of care in long-term care facilities can help identify influenza sooner for residents 65 and older with fever and respiratory symptoms.

  Recruiting China Medical University Hospital · Taichung · NCT07846423

• Egg-based H5N8 influenza vaccine at multiple doses with or without adjuvant in healthy adults

  This trial tests whether an egg-based H5N8 flu vaccine, given at low to high doses with or without an adjuvant, is safe and can provoke a stronger immune response in healthy adults 18 and older.

  Recruiting at 16 sites Phase 1/2 Sanofi · Tempe, Arizona and 15 other locations · NCT07779408

• Safety and PK of Ingavirin Forte vs Ingavirin in healthy adults under fasting and fed conditions

  This early-phase study tests whether Ingavirin Forte (90 mg + 20 mg) is safe and how it behaves in the body compared with Ingavirin (90 mg) in healthy adults aged 18–45, under different meal conditions.

  Recruiting Phase 1 Valenta Pharm JSC · Saint Petersburg · NCT07645534

• Virological Monitoring of Seasonal Respiratory Infections in France

  This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.

  Recruiting Institut National de la Santé Et de la Recherche Médicale, France · Paris · NCT07599449

• Flu vaccine strategies for adults with blood cancers

  This study will test three different flu vaccines to see which gives the strongest antibody and T-cell responses in adults with blood cancers, including people after autologous stem cell transplant or CAR-T therapy.

  Recruiting Phase 3 Asan Medical Center · Seoul · NCT07485855

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.